IP’s 1Q20 Profit Rockets 740% from Higher Sales Volume

Inter Pharma Public Company Limited (IP) has reported its 1Q20 consolidated financial statement through the Stock Exchange of Thailand as follows;

IP reported a net profit of 13.87 million baht in 1Q20, increased 740.61% when compared to a net profit of 1.6 million baht in 1Q19 mainly due to an increase in sales, reduced cost of sales and expenses which contribute to net profit margin of 14.91% of total revenue, moving up to 13.50% year-on-year.